Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection
- PMID: 11238211
- PMCID: PMC96052
- DOI: 10.1128/CDLI.8.2.293-296.2001
Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection
Abstract
The concentration of fecal mucin and the adhesion of specific probiotics and their combinations in the intestinal mucus of infants during and after rotavirus diarrhea and in healthy children were determined. Mucus was prepared from fecal samples from 20 infants during and after rotavirus diarrhea and from 10 healthy age-matched children. Mucin concentration was determined, and the adhesion of five probiotics-Lactobacillus rhamnosus GG, Lactobacillus casei Shirota, Lactobacillus paracasei F19, Lactobacillus acidophilus LA5, and Bifidobacterium lactis Bb12-and their combinations was tested in vitro. The mean concentrations of fecal mucin during and after rotavirus diarrhea, 15.2 and 14.1 mg/g, were comparable to that in healthy children, 14.9 mg/g. The adherence of probiotics ranged from 1 to 34% in healthy subjects as indicated for the following strains: L. rhamnosus GG, 34%; B. lactis Bb12, 31%; L. acidophilus LA5, 4%; L. paracasei F19, 3%; and L. casei Shirota, 1% (P = 0.0001). The distinctive pattern of probiotic adherence was not influenced by rotavirus diarrhea. The adhesion of Bb12 in the presence of GG increased from 31 to 39% in healthy infants (P = 0.018) and in episodes of diarrhea increased from 26 to 44% (P = 0.001). Rotavirus diarrhea does not decrease the production of fecal mucin or with respect to the adhesion of probiotic bacteria tested in vitro. Combination of specific probiotic strains may enhance adherence in a synergistic manner. Optimal clinical application of these interactions may offer novel therapeutic guidelines for the treatment and prevention of gastrointestinal infections.
Figures


Similar articles
-
The ability of probiotic bacteria to bind to human intestinal mucus.FEMS Microbiol Lett. 1998 Oct 15;167(2):185-9. doi: 10.1111/j.1574-6968.1998.tb13226.x. FEMS Microbiol Lett. 1998. PMID: 9809419
-
Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.Gut Microbes. 2014;5(5):639-51. doi: 10.4161/19490976.2014.969972. Gut Microbes. 2014. PMID: 25483333 Free PMC article.
-
Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus.Asia Pac J Clin Nutr. 2006;15(4):570-5. Asia Pac J Clin Nutr. 2006. PMID: 17077078 Review.
-
Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients.Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):237-44. doi: 10.1016/j.clinre.2014.09.006. Epub 2014 Nov 12. Clin Res Hepatol Gastroenterol. 2015. PMID: 25459995 Clinical Trial.
-
Probiotics for prevention and treatment of diarrhea.J Clin Gastroenterol. 2011 Nov;45 Suppl:S149-53. doi: 10.1097/MCG.0b013e3182257e98. J Clin Gastroenterol. 2011. PMID: 21992955 Review.
Cited by
-
Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048].BMC Pediatr. 2004 Sep 2;4:18. doi: 10.1186/1471-2431-4-18. BMC Pediatr. 2004. PMID: 15345099 Free PMC article. Clinical Trial.
-
Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.Endocrine. 2017 Nov;58(2):207-227. doi: 10.1007/s12020-017-1433-z. Epub 2017 Oct 19. Endocrine. 2017. PMID: 29052181 Review.
-
Promising clinical and immunological efficacy of Bacillus clausii spore probiotics for supportive treatment of persistent diarrhea in children.Sci Rep. 2024 Mar 18;14(1):6422. doi: 10.1038/s41598-024-56627-9. Sci Rep. 2024. PMID: 38494525 Free PMC article. Clinical Trial.
-
The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.Paediatr Drugs. 2015 Jun;17(3):199-216. doi: 10.1007/s40272-015-0124-6. Paediatr Drugs. 2015. PMID: 25799959 Free PMC article.
-
The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract.Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14422-7. doi: 10.1073/pnas.212527599. Epub 2002 Oct 15. Proc Natl Acad Sci U S A. 2002. PMID: 12381787 Free PMC article.
References
-
- Beachey E H. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis. 1981;143:325–345. - PubMed
-
- Carlstedt-Duke B. The normal microflora and mucin. In: Grubb R, Midtvedt T, Norin E, editors. The regulatory and protective role of the normal microflora. M. New York, N.Y: Stockton Press; 1989. pp. 109–127.
-
- Chen C C, Baylor M, Bass D M. Murine intestinal mucins inhibit rotavirus infection. Gastroenterology. 1993;105:84–92. - PubMed
-
- Cohen P S, Laux D C. Bacterial adhesion to and penetration of intestinal mucus in vitro. Methods Enzymol. 1995;253:309–314. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical